Overview
Heather Mannuel is an Oncologist practicing medicine in Baltimore, Maryland.
Dr. Mannuel is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma.
Dr. Mannuel is board certified in American Board Of Internal Medicine - Medical Oncology, 2010. She is actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 4 clinical trials. Dr. Mannuel is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
22 South Greene Street, Floor 1, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Stoler Outpatient Cancer Clinic
Taofeek Owonikoko is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine. Dr. Holdhoff is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner-Johnston is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wagner-Johnston is currently accepting new patients.
Frequently Asked Questions about Dr. Heather D. Mannuel
How do I make an appointment with Dr. Heather D. Mannuel?
You can book an appointment with Dr. Heather D. Mannuel by calling their office at 410-328-7609. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Heather D. Mannuel a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Heather D. Mannuel is classified as an Distinguished expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Heather D. Mannuel specialize in?
While Dr. Heather D. Mannuel is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Heather D. Mannuel participate in research or clinical trials?
Yes. Dr. Heather D. Mannuel has published 17 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Heather D. Mannuel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Heather D. Mannuel accept my insurance?
Dr. Heather D. Mannuel accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 410-328-7609 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Mannuel isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Mannuel isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Mannuel isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Mannuel isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Mannuel isDistinguished. Learn about Familial Wilms Tumor 2.
- Prostate CancerDr. Mannuel isDistinguished. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Mannuel isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Wilms TumorDr. Mannuel isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Mannuel isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Bladder CancerDr. Mannuel isAdvanced. Learn about Bladder Cancer.
- Testicular CancerDr. Mannuel isAdvanced. Learn about Testicular Cancer.
- Urothelial CancerDr. Mannuel isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Adrenal CancerDr. Mannuel isExperienced. Learn about Adrenal Cancer.
- ALK-Positive Non-Small Cell Lung CancerDr. Mannuel isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- ChoriocarcinomaDr. Mannuel isExperienced. Learn about Choriocarcinoma.
- EGFR Positive Lung CancerDr. Mannuel isExperienced. Learn about EGFR Positive Lung Cancer.
- Hereditary NeuroblastomaDr. Mannuel isExperienced. Learn about Hereditary Neuroblastoma.
- Large-Cell Lung CarcinomaDr. Mannuel isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Mannuel isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Mannuel isExperienced. Learn about Lung Cancer.
- MesotheliomaDr. Mannuel isExperienced. Learn about Mesothelioma.
- Muscle Invasive Bladder CancerDr. Mannuel isExperienced. Learn about Muscle Invasive Bladder Cancer.
- NeuroblastomaDr. Mannuel isExperienced. Learn about Neuroblastoma.
- Non-Muscle Invasive Bladder CancerDr. Mannuel isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Mannuel isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Paroxysmal Nocturnal Hemoglobinuria (PNH)Dr. Mannuel isExperienced. Learn about Paroxysmal Nocturnal Hemoglobinuria (PNH).
- Penile CancerDr. Mannuel isExperienced. Learn about Penile Cancer.
- Pleuropulmonary BlastomaDr. Mannuel isExperienced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Mannuel isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Mannuel isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Teratoma of the MediastinumDr. Mannuel isExperienced. Learn about Teratoma of the Mediastinum.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Mannuel isExperienced. Learn about Upper Tract Urothelial Carcinoma (UTUC).

